Literature DB >> 30264708

GLOBOCAN 2018: counting the toll of cancer.

.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30264708     DOI： 10.1016/S0140-6736(18)32252-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  60 in total

Review 1.  Evolving the pulmonary nodules diagnosis from classical approaches to deep learning-aided decision support: three decades' development course and future prospect.

Authors:  Bo Liu; Wenhao Chi; Xinran Li; Peng Li; Wenhua Liang; Haiping Liu; Wei Wang; Jianxing He
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-30       Impact factor: 4.553

2.  ST08 Altered NF-κB Pathway in Breast Cancer Cells In Vitro as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model.

Authors:  Snehal Nirgude; Sagar Desai; Raghunandan Mahadeva; Febina Ravindran; Bibha Choudhary
Journal:  Front Oncol       Date:  2022-05-09       Impact factor: 5.738

Review 3.  Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.

Authors:  Vaishali Aggarwal; Kumari Priyanka; Hardeep Singh Tuli
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

Review 4.  Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis.

Authors:  Michael M Jonczyk; Jolie Jean; Roger Graham; Abhishek Chatterjee
Journal:  Breast Cancer Res Treat       Date:  2018-10-25       Impact factor: 4.872

5.  Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Multi-Parametric MRI Radiomics.

Authors:  Yang Zhang; Zhenyu Shu; Qin Ye; Junfa Chen; Jianguo Zhong; Hongyang Jiang; Cuiyun Wu; Taihen Yu; Peipei Pang; Tianshi Ma; Chunmiao Lin
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

Review 6.  Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer.

Authors:  Molly A Nelson; Worapol Ngamcherdtrakul; Shiuh-Wen Luoh; Wassana Yantasee
Journal:  Cancer Metastasis Rev       Date:  2021-05-07       Impact factor: 9.237

7.  Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of Uganda.

Authors:  Godfrey Osinde; Nixon Niyonzima; Vivienne Mulema; Deo Kyambadde; Yusuf Mulumba; Siraj Obayo; Ezra Anecho; Susan Watera; Mughuma Constance; Sylivestor Kadhumbula; Jackson Orem
Journal:  Future Oncol       Date:  2021-04-15       Impact factor: 3.674

8.  Leveraging a matrix of stakeholders to facilitate access to chemotherapy for women's cancers in the Democratic Republic of the Congo.

Authors:  Tankoy Gombo YouYou; Kabongo Mukuta Mathieu; Michael L Hicks; Ronda Henry-Tillman; Alex Mutombo; Mukanya Mpalata Anaclet; Mulumba Kapuku Sylvain; Maya M Hicks; Leeya Pinder; Louis Kanda; Mirielle Kanda; Groesbeck P Parham
Journal:  Ecancermedicalscience       Date:  2021-05-13

Review 9.  The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research.

Authors:  Priya Ranganathan; Girish Chinnaswamy; Manju Sengar; Durga Gadgil; Shivakumar Thiagarajan; Balram Bhargava; Christopher M Booth; Marc Buyse; Sanjiv Chopra; Chris Frampton; Satish Gopal; Nick Grant; Mark Krailo; Ruth Langley; Prashant Mathur; Xavier Paoletti; Mahesh Parmar; Arnie Purushotham; Douglas Pyle; Preetha Rajaraman; Martin R Stockler; Richard Sullivan; Soumya Swaminathan; Ian Tannock; Edward Trimble; Rajendra A Badwe; C S Pramesh
Journal:  Lancet Oncol       Date:  2021-06-30       Impact factor: 54.433

10.  Establishing women's cancer care services in a fragile, conflict and violence affected ecosystem in Africa.

Authors:  Groesbeck Preer Parham; Kabongo Mukuta Mathieu; Tankoy Gombo YouYou; Michael L Hicks; Ronda Henry-Tillman; Alex Mutombo; Mukanya Mpalata Anaclet; Mulumba Kapuku Sylvain; Leeya Pinder; Maya M Hicks; Louis Kanda; Mirielle Kanda
Journal:  Ecancermedicalscience       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.